Literature DB >> 10052111

Colonic neuroendocrine peptide levels in patients with chronic idiopathic slow transit constipation.

M el-Salhy1, O Norrgård.   

Abstract

The motility disorders in patients with slow-transit constipation have been attributed to a disturbance in the peptidergic innervation of the colonic enteric nervous system. The nature of this disturbance is, however, controversial. In the present study 7 patients with long-standing severe slow- transit constipation were included, and normal tissues from the colon of 6 patients, which had undergone colonectomy because of polyp, chronic diverticulitis, prolapsis and volvulus were used as controls. The concentrations of several neuroendocrine peptides were measured in tissue extracts by radioimmuno-assays. The level of pancreatic polypeptide was high in 2 patients and low in one patient. Peptide YY level was high in 3 patients and low in one patient, and that of neuropeptide Y was high in 4 patients. Somatostatin and vasoactive intestinal polypeptide levels were high in 3 patients and substance P concentration was low in 3 patients. Neurotensin level was high in one patient and low in another patient. Galanin concentration was low in 2 patients and high in one patient. Gastrin-releasing peptide level was high in one patient and that of enkephalin was high in 2 patients. All patients had altered concentrations of several neuroendocrine peptides except one, who had only a low level of galanin. It is concluded that patients with slow-transit constipation have disturbed neuroendocrine peptides in common, though the nature of this disturbance varies between patients and in most patients several neuroendocrine peptides were affected. This may explain the controversial results obtained in previous studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10052111     DOI: 10.3109/03009739809178951

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  10 in total

1.  Progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA expression in non-tumor tissues of the human gastrointestinal tract.

Authors:  Hans-Jurg Monstein; Niclas Grahn; Mikael Truedsson; Bodil Ohlsson
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

Review 2.  Racecadotril versus loperamide: antidiarrheal research revisited.

Authors:  S Huighebaert; F Awouters; G N J Tytgat
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

3.  The evaluation of constipation.

Authors:  Matthew D Vrees; Eric G Weiss
Journal:  Clin Colon Rectal Surg       Date:  2005-05

Review 4.  The role of peptide YY in gastrointestinal diseases and disorders (review).

Authors:  Magdy El-Salhy; Tarek Mazzawi; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2012-12-21       Impact factor: 4.101

5.  Preventive effect of Dendrobium candidum Wall. ex Lindl. on activated carbon-induced constipation in mice.

Authors:  Rui Wang; Peng Sun; Yalin Zhou; Xin Zhao
Journal:  Exp Ther Med       Date:  2014-12-08       Impact factor: 2.447

6.  Preventive effect of Lactobacillus fermentum Lee on activated carbon-induced constipation in mice.

Authors:  Yu Qian; Huayi Suo; Muying DU; Xin Zhao; Jian Li; Gui-Jie Li; Jia-Li Song; Zhenhu Liu
Journal:  Exp Ther Med       Date:  2014-11-11       Impact factor: 2.447

7.  Bifidobacterium adolescentis Exerts Strain-Specific Effects on Constipation Induced by Loperamide in BALB/c Mice.

Authors:  Linlin Wang; Lujun Hu; Qi Xu; Boxing Yin; Dongsheng Fang; Gang Wang; Jianxin Zhao; Hao Zhang; Wei Chen
Journal:  Int J Mol Sci       Date:  2017-02-20       Impact factor: 5.923

8.  Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by Ligilactobacillus salivarius Li01.

Authors:  Bo Qiu; Lian Zhu; Shuobo Zhang; Shengyi Han; Yiqiu Fei; Furong Ba; Björn Berglund; Lanjuan Li; Mingfei Yao
Journal:  Nutrients       Date:  2022-10-01       Impact factor: 6.706

9.  Preventive effect of resistant starch on activated carbon-induced constipation in mice.

Authors:  Yu Qian; Xin Zhao; Jianquan Kan
Journal:  Exp Ther Med       Date:  2013-05-01       Impact factor: 2.447

10.  Potential role of fecal microbiota in patients with constipation.

Authors:  Yan Tian; Luo Zuo; Qin Guo; Jun Li; Zhangyong Hu; Kui Zhao; Can Li; Xiaohui Li; Jinggang Zhou; Yan Zhou; Xiao-An Li
Journal:  Therap Adv Gastroenterol       Date:  2020-10-31       Impact factor: 4.409

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.